2026 data FDA MAUDE openFDA

Reagent Red Blood Cells

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA MAUDE casebook

openFDA event book Reagent Red Blood Cells LIGHT-BOOK · MAUDE

#980 of 1000 · 389 reports · 2018–2026

  • BOOK 389 reports
  • RANK #980 of 1000
  • DEATH 2 death-typed
  • INJ 2 injury-typed
  • MALF 385 malfunction
  • SPAN 2018–2026
  • PEAK 2020: 89
  • PHOTO Accessories

Nearest event-volume peer: Accessories, Catheter, G-U (3 report gap)

Reagent Red Blood Cells sits #980 of 1000 among tracked device types with 389 MAUDE reports spanning 2018–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Malfunction reports run above the device-type norm

Reagent Red Blood Cells carries 99.0% MALFUNCTION-coded reports, 34.1pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 0.5% corpus 1.5% · below corpus mean (-1.0 pp)
  • INJ 0.5% corpus 30.3% · below corpus mean (-29.8 pp)
  • MALF 99.0% corpus 64.8% · above corpus mean (+34.1 pp)

Lead product-problem code False Negative Result is 70% of coded problems · Lead manufacturer ORTHO CLINICAL DIAGNOSTICS accounts for 100% of manufacturer-tagged reports · Top event location is 62% of location-tagged rows .

Reagent Red Blood Cells in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Reagent Red Blood Cells carries 389 MAUDE reports, ranked #980 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 385 (99.0%)
Death 2 (0.5%)
Injury 2 (0.5%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

379 (99.0%)
Death 2 (0.5%)
Required Intervention 2 (0.5%)

Top Product Problems

False Negative Result 285
Adverse Event Without Identified Device or Use Problem 38
Incorrect, Inadequate or Imprecise Result or Readings 32
False Positive Result 24
No Apparent Adverse Event 11
Off-Label Use 6
Defective Device 3
Imprecise or Erratic Results 2
Improper Chemical Reaction 2
Break 1
Cross Reactivity 1
Defective Component 1
Therapeutic or Diagnostic Output Failure 1

Yearly Trend

18
2018: 3
19
2019: 14
20
2020: 89
21
2021: 60
22
2022: 48
23
2023: 45
24
2024: 54
25
2025: 51
26
2026: 25

Reports in 2025 (51) held close to the prior two-year average of 50.

Related Entities for Reagent Red Blood Cells

Top Manufacturers

Event Locations

243 (62.5%)
I 146 (37.5%)

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Reagent Red Blood Cells: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (389 here).

Similar death-typed counts

Nearest other device types by death-typed report count (2 here), distinct from the volume row.

Disclaimer: MAUDE figures for Reagent Red Blood Cells are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Reagent Red Blood Cells; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.